Inogen Inc (INGN)

$7.75 +0.22 (2.92%)
Market Cap 209.56M
Revenue (ttm) 335.71M
Net Income (ttm) -35.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.69%
Debt to Equity Ratio 0.00
Volume 203,400
Avg Vol 230,122
Day's Range N/A - N/A
Shares Out 27.04M
Stochastic %K 85%
Beta 1.72
Analysts Sell
Price Target $11.00

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators;...

Industry: Medical Devices
Sector: Healthcare
Phone: 805 562 0500
Address:
859 Ward Drive, Goleta, United States
Rebexxinfx
Rebexxinfx Aug. 14 at 7:19 PM
$RILY just want to draw your attention to this guy that BRiley just initiated coverage on with a buy rating : $INGN. Calls are ridiculous cheap, moderately low float and she’s heating up
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 14 at 7:16 PM
$INGN $10 calls Sept19 .05 don’t mind if I dooooooooooooooooooo
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 14 at 5:53 PM
$INGN golden cross incoming? 👀
0 · Reply
assisi
assisi Aug. 12 at 4:35 PM
@sogenerous thoughts on $INGN
0 · Reply
mmqwerty00
mmqwerty00 Aug. 12 at 2:17 AM
$INGN Be patient - will run more...Current assets @ 203M - TOTAL liability (including all the nonsense reserves, deferreds, etc.) is 112M - thats a 91M net. I'd note that ignores all the fixed assets too - that is purely current assets less TOTAL liabilities. Market cap is 189M - market is valuing this company's business and all its fixed assets still @ < 100M with a) increased guidance, b) over 350m of sales for the year and c) back to adjusted EBITDA breakeven. Sorry - but you really mean to tell me that the business over asset value is worth < 100M? Don't buy it. Be patient. It will hit double digits again - even at 10/share its a 268M market cap, which when you back out above still puts this thing at a valuation of the business itself/fixed assets at less than < 0.5 sales. Its recovering
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 5:45 PM
$INGN narrows Q2 loss, beats revenue estimates — but is the turnaround real? 📈 Inogen posted a narrower-than-expected adjusted loss per share of 2 cents, topping the Zacks Consensus Estimate of a 22-cent loss, with sales revenues increasing 4% year over year. Yet, the stock is still down 36% YTD despite a 2.7% pre-market rise today. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2684701/inogen-stock-gains-following-q2-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2684701-body-7007&ADID=SYND_STOCKTWITS_TWEET_2_2684701_BODY_7007
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 4:39 PM
$INGN pops on Q2 beat — but is the rally just getting started? Loss narrowed and revenue climbed 4% Y/Y, powered by strong B2B demand even as DTC and rental segments slipped. Full breakdown here 👉 https://www.zacks.com/stock/news/2684701/inogen-stock-gains-following-q2-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2684701-teaser-6960&ADID=SYND_STOCKTWITS_TWEET_2_2684701_TEASER_6960
0 · Reply
zecca1889
zecca1889 Aug. 7 at 9:24 PM
$INGN It can only get better
0 · Reply
mmqwerty00
mmqwerty00 Aug. 1 at 2:32 AM
$INGN Compare the current assets to the total liabilities and its +90M as of 3/31 - right now this is a 170MC - you think their entire business isn't worth more than 80M. Really? They are guiding 350M+ of sales at EBITDA breakeven with 5-6% growth. No reason why this stock shouldnt be a 10+. Discount the 90M of actual assets on the books. At 10 that values the business at < 180M or about 0.5 sales. Buy it and be patient. May be a wait but no reason why over the next 12-18 months this isn't over 10+ - they have plenty of cash - the business is there and recovering. Its a solid buy
0 · Reply
ZacksResearch
ZacksResearch Jul. 16 at 2:29 PM
$INGN poised for growth — why the POC market is a game-changer! 🚀 🩺 First-quarter revenues up 5.5% YoY, with domestic sales rising 29.9% and international sales increasing 22.9%. 📈 POCs market projected to grow from $15.05B in 2024 to $22.63B by 2029. 💡 New product launches like Voxi 5 & strategic collaborations to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2585365/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2585365-body-2050&ADID=SYND_STOCKTWITS_TWEET_2_2585365_BODY_2050
0 · Reply
Latest News on INGN
Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 6:18 PM EDT - 16 days ago

Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript

Inogen Announces Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 17 days ago

Inogen Announces Second Quarter 2025 Financial Results

Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:30 AM EDT - 5 weeks ago

Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

Jun 23, 2025, 8:30 AM EDT - 2 months ago

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 22, 2025, 1:38 PM EDT - 3 months ago

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 8:16 PM EDT - 3 months ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

Inogen Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 3 months ago

Inogen Announces First Quarter 2025 Financial Results

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Mar 20, 2025, 8:30 AM EDT - 5 months ago

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

A Volatile Share Price Masks Some Of The Progress At Inogen

Mar 1, 2025, 8:56 AM EST - 6 months ago

A Volatile Share Price Masks Some Of The Progress At Inogen

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 26, 2025, 4:21 PM EST - 6 months ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 8:03 PM EST - 6 months ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 4:05 PM EST - 6 months ago

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Feb 3, 2025, 4:00 PM EST - 7 months ago

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Jan 26, 2025, 10:17 PM EST - 7 months ago

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Jan 26, 2025, 12:00 PM EST - 7 months ago

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Jan 13, 2025, 4:00 PM EST - 7 months ago

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Dec 30, 2024, 8:30 AM EST - 8 months ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:55 PM EST - 10 months ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Inogen Announces Third Quarter 2024 Financial Results

Nov 7, 2024, 4:05 PM EST - 10 months ago

Inogen Announces Third Quarter 2024 Financial Results

Inogen to Present at Upcoming Investor Conferences

Nov 4, 2024, 8:30 AM EST - 10 months ago

Inogen to Present at Upcoming Investor Conferences

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 17, 2024, 8:30 AM EDT - 11 months ago

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Oct 8, 2024, 8:30 AM EDT - 11 months ago

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 9:11 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Inogen Announces Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Second Quarter 2024 Financial Results

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 16, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Jul 3, 2024, 4:10 PM EDT - 1 year ago

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

Jun 3, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 10:30 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

Inogen Announces First Quarter 2024 Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces First Quarter 2024 Financial Results

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Mar 25, 2024, 8:30 AM EDT - 1 year ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Mar 7, 2024, 4:00 PM EST - 1 year ago

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 7:09 PM EST - 1 year ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Feb 27, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Jan 30, 2024, 4:00 PM EST - 1 year ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Inogen Names Michael Bourque as New Chief Financial Officer

Jan 24, 2024, 4:00 PM EST - 1 year ago

Inogen Names Michael Bourque as New Chief Financial Officer

Inogen: Time To Be Greedy When Others Are Fearful

Jan 1, 2024, 8:47 AM EST - 1 year ago

Inogen: Time To Be Greedy When Others Are Fearful

Inogen to Present at Upcoming Investor Conferences in November 2023

Nov 9, 2023, 2:30 PM EST - 1 year ago

Inogen to Present at Upcoming Investor Conferences in November 2023

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 11:08 PM EST - 1 year ago

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Inogen Announces Third Quarter 2023 Financial Results

Nov 7, 2023, 4:05 PM EST - 1 year ago

Inogen Announces Third Quarter 2023 Financial Results

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Oct 10, 2023, 4:00 PM EDT - 2 years ago

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Inogen Completes Acquisition of Physio-Assist

Sep 18, 2023, 8:30 AM EDT - 2 years ago

Inogen Completes Acquisition of Physio-Assist

Inogen Announces CFO Transition Plan

Sep 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Announces CFO Transition Plan

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

Inogen, Inc. (INGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 9:46 PM EDT - 2 years ago

Inogen, Inc. (INGN) Q2 2023 Earnings Call Transcript

Inogen Announces Second Quarter 2023 Financial Results

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Inogen Announces Second Quarter 2023 Financial Results

Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators

Aug 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me

Jul 18, 2023, 8:54 AM EDT - 2 years ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me

FGEN SILK THRX

Inogen: Still Struggling, But Very Cheap - Upgrading To Buy

Jul 13, 2023, 10:13 PM EDT - 2 years ago

Inogen: Still Struggling, But Very Cheap - Upgrading To Buy

Rebexxinfx
Rebexxinfx Aug. 14 at 7:19 PM
$RILY just want to draw your attention to this guy that BRiley just initiated coverage on with a buy rating : $INGN. Calls are ridiculous cheap, moderately low float and she’s heating up
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 14 at 7:16 PM
$INGN $10 calls Sept19 .05 don’t mind if I dooooooooooooooooooo
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 14 at 5:53 PM
$INGN golden cross incoming? 👀
0 · Reply
assisi
assisi Aug. 12 at 4:35 PM
@sogenerous thoughts on $INGN
0 · Reply
mmqwerty00
mmqwerty00 Aug. 12 at 2:17 AM
$INGN Be patient - will run more...Current assets @ 203M - TOTAL liability (including all the nonsense reserves, deferreds, etc.) is 112M - thats a 91M net. I'd note that ignores all the fixed assets too - that is purely current assets less TOTAL liabilities. Market cap is 189M - market is valuing this company's business and all its fixed assets still @ < 100M with a) increased guidance, b) over 350m of sales for the year and c) back to adjusted EBITDA breakeven. Sorry - but you really mean to tell me that the business over asset value is worth < 100M? Don't buy it. Be patient. It will hit double digits again - even at 10/share its a 268M market cap, which when you back out above still puts this thing at a valuation of the business itself/fixed assets at less than < 0.5 sales. Its recovering
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 5:45 PM
$INGN narrows Q2 loss, beats revenue estimates — but is the turnaround real? 📈 Inogen posted a narrower-than-expected adjusted loss per share of 2 cents, topping the Zacks Consensus Estimate of a 22-cent loss, with sales revenues increasing 4% year over year. Yet, the stock is still down 36% YTD despite a 2.7% pre-market rise today. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2684701/inogen-stock-gains-following-q2-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2684701-body-7007&ADID=SYND_STOCKTWITS_TWEET_2_2684701_BODY_7007
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 4:39 PM
$INGN pops on Q2 beat — but is the rally just getting started? Loss narrowed and revenue climbed 4% Y/Y, powered by strong B2B demand even as DTC and rental segments slipped. Full breakdown here 👉 https://www.zacks.com/stock/news/2684701/inogen-stock-gains-following-q2-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2684701-teaser-6960&ADID=SYND_STOCKTWITS_TWEET_2_2684701_TEASER_6960
0 · Reply
zecca1889
zecca1889 Aug. 7 at 9:24 PM
$INGN It can only get better
0 · Reply
mmqwerty00
mmqwerty00 Aug. 1 at 2:32 AM
$INGN Compare the current assets to the total liabilities and its +90M as of 3/31 - right now this is a 170MC - you think their entire business isn't worth more than 80M. Really? They are guiding 350M+ of sales at EBITDA breakeven with 5-6% growth. No reason why this stock shouldnt be a 10+. Discount the 90M of actual assets on the books. At 10 that values the business at < 180M or about 0.5 sales. Buy it and be patient. May be a wait but no reason why over the next 12-18 months this isn't over 10+ - they have plenty of cash - the business is there and recovering. Its a solid buy
0 · Reply
ZacksResearch
ZacksResearch Jul. 16 at 2:29 PM
$INGN poised for growth — why the POC market is a game-changer! 🚀 🩺 First-quarter revenues up 5.5% YoY, with domestic sales rising 29.9% and international sales increasing 22.9%. 📈 POCs market projected to grow from $15.05B in 2024 to $22.63B by 2029. 💡 New product launches like Voxi 5 & strategic collaborations to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2585365/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2585365-body-2050&ADID=SYND_STOCKTWITS_TWEET_2_2585365_BODY_2050
0 · Reply
ZacksResearch
ZacksResearch Jul. 16 at 12:50 PM
$INGN looks ready to breathe new life into your portfolio 👀 Expanding its product lineup and strong potential in portable oxygen concentrators (POC) are fueling bullish sentiment. Full breakdown here 👉 https://www.zacks.com/stock/news/2585365/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2585365-teaser-1977&ADID=SYND_STOCKTWITS_TWEET_2_2585365_TEASER_1977
0 · Reply
MoneyTree82
MoneyTree82 Jun. 17 at 4:53 PM
$INGN low float very few shares available… would take much for this to pop hard!
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 5:32 PM
B. Riley Securities has updated their rating for Inogen ( $INGN ) to Buy with a price target of 14.
0 · Reply
ZacksResearch
ZacksResearch May. 28 at 2:50 PM
Is $INGN set for a rebound? 📈 Despite a 21.4% decline so far this year, Inogen's strong Q1 results and attractive P/S ratio of 0.6X vs. the industry's 2.6X show promise. The Zacks Rank #2 stock also projects 7.2% earnings growth for 2025, with continued momentum in the POC space. See why this could be a buying opportunity 👉 https://www.zacks.com/commentary/2478116/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2478116-body&ADID=SYND_STOCKTWITS_TWEET_2_2478116_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 28 at 12:47 PM
Expanding product portfolio and high prospects for POC raise optimism for $INGN stock. Explore further: https://www.zacks.com/stock/news/2478116/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2478116-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2478116_TEASER
0 · Reply
MoneyTree82
MoneyTree82 May. 27 at 2:38 PM
$INGN only 26 million share with improving revenues 💪
0 · Reply
ZacksResearch
ZacksResearch May. 27 at 1:12 PM
Broker upgrades boost $URBN, $INGN and $SWX, with earnings growth and strong Zacks Ranks signaling potential upside despite market volatility. Here's more: https://www.zacks.com/stock/news/2477604/3-stocks-with-upgraded-broker-ratings-to-bet-on-amid-uncertainties?cid=sm-stocktwits-2-2477604-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477604_TEASER
0 · Reply
ZacksResearch
ZacksResearch May. 27 at 12:12 PM
Trade war jitters or a buying opportunity? Here's why $URBN, $INGN & $SWX might shine! 🚀 ✅ Urban Outfitters: Fiscal 2026 earnings to rise 20% with a 9.1% broker rating upgrade. ✅ Inogen: 2025 earnings projected to grow 24.3%, broker ratings up 25%. ✅ Southwest Gas: 2025 earnings expected to increase 18.4%, with a 14.3% broker rating boost. Discover the full potential here 👉 https://www.zacks.com/commentary/2477604/3-stocks-with-upgraded-broker-ratings-to-bet-on-amid-uncertainties?cid=sm-stocktwits-2-2477604-body&ADID=SYND_STOCKTWITS_TWEET_2_2477604_BODY
0 · Reply
RunnerSignals
RunnerSignals May. 22 at 9:39 PM
Fresh Upgrades and Downgrades After-Hours! $CR $INGN $GRFS $MU $SWK and more in play! Analysts reshuffled the deck - who's your pick going into Friday? stocksrunner.com/news/2025-05-22-thursday-analyst-upgrades-and-downgrades
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 22 at 4:02 PM
$INGN Inogen shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a $12 price target.
1 · Reply
erevnon
erevnon May. 22 at 11:22 AM
Needham upgrades Inogen $INGN from Hold to Buy and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow May. 22 at 10:30 AM
Needham updates rating for Inogen ( $INGN ) to Buy, target set at 12.
0 · Reply